Vestagen Technical Textiles is a technology company.
Vestagen Technical Textiles has raised $7.8M across 2 funding rounds.
Vestagen Technical Textiles has raised $7.8M in total across 2 funding rounds.
Vestagen Technical Textiles has raised $7.8M in total across 2 funding rounds.
Vestagen Technical Textiles's investors include HealthQuest Capital.
Vestagen Technical Textiles (also known as Vestagen Protective Technologies) is a technology company that develops, manufactures, and markets advanced performance textile products, primarily VESTEX® active barrier fabrics for healthcare apparel.[1][2][3][4] These fabrics serve healthcare workers, patients, first responders, and athletic users by solving the problem of pathogen transmission, fluid exposure, and discomfort in traditional scrubs and uniforms through fluid-repelling, moisture-wicking, and antimicrobial properties that reduce risks from bacteria like MRSA and coronaviruses in under 15 minutes.[1][3][4] With FDA-cleared products, the company has raised $35.9M in funding across 6 rounds (most recent $9.5M), employs 51-200 people, and generates $1M-$5M in revenue from direct sales and distributors, headquartered in Orlando, Florida.[1][3][4]
Founded by Ben Favret, Vestagen Technical Textiles emerged to innovate in medical textiles, securing exclusive North American rights to patented Swiss technologies for adaptable fabrics used in uniforms and apparel.[1][2] The idea stemmed from addressing unmet needs in healthcare for continuous-wear garments that protect against fluids, perspiration, and microbes, transforming standard scrubs into FDA-cleared medical devices.[1][3][5][6] A pivotal rebranding in 2016 to Vestagen Protective Technologies, Inc. launched the "VESTEX Now Market Adoption Program," accelerating commercialization; early recognition included a 2017 Innovative Technology designation from Vizient for its healthcare worker apparel.[4][7]
Vestagen rides the wave of infection control and PPE innovation, amplified by post-COVID emphasis on healthcare worker safety and antimicrobial materials amid rising hospital-acquired infections.[1][4] Timing aligns with market forces like regulatory pushes for advanced textiles and supply chain shifts toward U.S.-based manufacturing, positioning it favorably in the $multi-billion medical apparel sector.[1][3] By influencing standards for "smart" fabrics—blending tech like antimicrobials with wearability—Vestagen contributes to the ecosystem, enabling safer environments and inspiring cross-industry adaptations in protective gear.[4]
Vestagen is poised for expansion into global markets and new sectors like athletics, leveraging its Swiss-tech foundation and funding to scale production amid ongoing pathogen threats.[1][4] Trends in sustainable, tech-infused textiles and AI-driven fabric R&D will shape its path, potentially through acquisitions or partnerships to broaden VESTEX applications. Its influence may evolve from niche innovator to category leader in protective apparel, reinforcing the high-level promise of revolutionizing everyday healthcare gear with barrier technologies that save lives.
Vestagen Technical Textiles has raised $7.8M across 2 funding rounds. Most recently, it raised $800K Venture Round in December 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2014 | $800K Venture Round | HealthQuest Capital | |
| Dec 1, 2013 | $7.0M Series A | HealthQuest Capital |